Characterization of Membrane-Associated Progesterone Receptor Component-2 (MAPRC2) from Trichinella spiralis and Its Interaction with Progesterone and Mifepristone
نویسندگان
چکیده
Trichinellosis is a foodborne zoonotic disease caused by Trichinella spp., including spiralis. In the present study, T. spiralis membrane-associated progesterone receptor component-2 (Ts-MAPRC2) gene was cloned and characterized using protein sequencing analysis. Furthermore, expression, purification, immunoblot assay, binding ability with antibody, immunofluorescence assay were performed. A direct effect of (P4) mifepristone (RU486) on Ts-MAPRC2 determined in vitro cell culture that showed different expression levels at all developmental stages (muscle larvae (ML), female adult worm (F-AL), male (M-AL), newborn (NBL)). Subsequently, phenotypic effects P4, RU486, rTs-MAPRC2-Ab F-AL ML measured. Later, vivo relative mRNA stage studied. Our results revealed critical to maintaining pregnancy (F-AL) The 300 ng/mL P4 100 RU486 downregulation (p ≤ 0.05). This plays an important role abortion possibly decreases burden host. Only 30 significant upregulation current study provides new insights regarding antihormone (P4 RU486) drug design vaccine therapy recombinant (rTs-MAPRC2) as well their combined control infection.
منابع مشابه
Cloning, mapping and molecular characterization of porcine progesterone receptor membrane component 2 (PGRMC2) gene
Progesterone plays an important role in sow reproduction by stimulating classic genomic pathways via nuclear receptors and non-genomic pathways via membrane receptors such a progesterone receptor membrane component 2 (PGRMC2). In this work, we used radiation hybrid mapping to assign PGRMC2 to pig chromosome 8 and observed that this receptor has two transcripts in pigs. The full-length cDNA of t...
متن کاملIdentification of the Sigma-2 Receptor: Distinct from the Progesterone Receptor Membrane Component 1 (PGRMC1)
The sigma receptor (σR) subtypes, σ1 and σ2, have been mischaracterized [1,2]. A recent study suggested that the σ2R is the progesterone receptor membrane component 1 (PGRMC1) in rat livers. This finding was supported by the use of a novel photo affinity probe for σ2Rs, 5-[3-(4-[4azido2(4[6,7dimethoxy3,4dihydroisoquinolin 2(1H)yl]butylcarbamoyl)phenoxy]butyl)thioureido]-2-(6-hydroxy-3-oxo-3H-xa...
متن کاملEffects of progesterone and its antagonist mifepristone on progesterone receptor a expression in human umbilical vein endothelial cells.
Effects of female steroid hormones on endothelial cells are gaining increased importance due to several studies on the effects of hormonal treatment on cardiovascular risk. Recent data argue for an improvement of endothelium-derived relaxation and impaired vascular contraction by estradiol, whereas progesterone and testosterone might entail contrary effects. So far, gestagenic influence on endo...
متن کاملCharacterization of Progesterone Receptor Membrane Component 1 in Peripheral Blood Mononuclear Cells and Plasma during Pregnancy
Objective: Progesterone receptor membrane component 1 (PGRMC1) is a novel membrane progesterone receptor that is highly expressed and actively regulated in gestational tissues. Research suggests that PGRMC1 plays a role in mediating progesterone function in gestational tissues and maintaining pregnancy. It has also been reported that PGRMC1 is detectable in the plasma and peripheral blood monon...
متن کاملProgesterone receptor membrane component-1 regulates hepcidin biosynthesis.
Iron homeostasis is tightly regulated by the membrane iron exporter ferroportin and its regulatory peptide hormone hepcidin. The hepcidin/ferroportin axis is considered a promising therapeutic target for the treatment of diseases of iron overload or deficiency. Here, we conducted a chemical screen in zebrafish to identify small molecules that decrease ferroportin protein levels. The chemical sc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccines
سال: 2021
ISSN: ['2076-393X']
DOI: https://doi.org/10.3390/vaccines9080934